Core Scientific, Inc. CORZ
17.34
(0.79)
(4.36%)
as of 25 Sep
- Market cap
- $5.9B
- P/E
- 0.0×
Follow CORZ
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | |
|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
14.52 | 7.04 | 2.60 | 2.60 | 2.60 | 2.60 |
P/FCF ratio |
0.00 | 0.00 | 27.16 | 27.16 | 27.16 | 27.16 |
P/Operating CF |
30.26 | 260.37 | 60.21 | 60.21 | 60.21 | 60.21 |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
16.86 | 7.50 | 3.90 | 3.90 | 3.90 | 3.90 |
EV/EBITDA |
0.00 | 0.00 | 18.43 | 18.43 | 18.43 | 18.43 |
EV/Operating CF |
19.34 | 89.32 | 30.05 | 30.05 | 30.05 | 30.05 |
EV/FCF |
(11.76) | (73.26) | 40.67 | 40.67 | 40.67 | 40.67 |
Quick Ratio |
0.40 | 6.22 | 0.14 | 0.28 | 0.42 | — |
Current Ratio |
1.15 | 6.72 | 0.20 | 0.46 | 2.36 | — |
Net Debt/EBITDA |
(4.70) | (13.03) | 6.12 | 0.23 | 3.51 | 0.00 |
Debt/Assets |
45.17% | 72.77% | 101.08% | 0.00% | 29.29% | 0.00% |
Debt/Equity |
(1.10) | (1.14) | (1.21) | 0.00 | 0.53 | 0.00 |
Asset Turnover |
0.17 | 0.47 | 0.66 | 0.39 | 0.45 | 0.00 |
Operating CF/Net income |
(0.96) | (0.03) | (0.26) | (0.10) | (1.20) | 1.05 |
Capex/Depreciation |
(8.54) | (0.77) | (0.17) | (0.31) | (1.69) | (0.15) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 30.29% | 186.74% | 48.99% | (460.65%) | 0.00% | 0.00% | |
| (15.10%) | (131.43%) | (32.44%) | (132.22%) | 3.88% | 0.00% | |
ROIC |
0.00% | 0.00% | 10.53% | 0.00% | 4.27% | 0.00% |
Return on Tangible Assets |
(20.51%) | (119.54%) | (127.04%) | (364.12%) | 4.58% | 0.00% |
Average Days of Receivables |
0.00 | 0.00 | 0.73 | 0.15 | 1.13 | 0.00 |
Research and Development Expense of Revenue |
49.91% | 22.26% | 21.52% | 4.21% | 1.41% | 8.74% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 35.30% | 11.85% | 27.06% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.44 | 0.00 |
Share Based Compensation of Revenue |
30.79% | 10.17% | 11.72% | 28.56% | 7.15% | 5.03% |
Graham Net Nets |
(0.52) | (0.42) | (0.93) | (0.93) | (0.93) | (0.93) |
Graham Number |
9.65 | 21.10 | 4.77 | 13.05 | 5.76 | 0.00 |
Earnings Yield |
(9.38%) | (38.22%) | (18.70%) | (18.70%) | (18.70%) | (18.70%) |
Free Cash Flow Yield |
(9.88%) | (1.45%) | 3.68% | 3.68% | 3.68% | 3.68% |
Revenue per Share |
1.00 | 2.00 | 1.32 | 1.88 | 2.63 | 0.38 |
Operating CF per Share |
0.87 | 0.17 | 0.17 | 0.60 | (0.27) | (0.15) |
Capex per Share |
(2.31) | (0.37) | (0.04) | (1.73) | (0.28) | (0.01) |
Free Cash Flow per Share |
(1.44) | (0.20) | 0.13 | (1.13) | (0.56) | (0.16) |
Cash per Share |
0.98 | 3.27 | 0.18 | 0.15 | 0.64 | 0.00 |
Shareholders Equity per Share |
(3.03) | (3.69) | (1.57) | (1.20) | 6.47 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(3.03) | (3.69) | (1.57) | (1.20) | 6.47 | 0.00 |
Free Cash Flow |
(457.50) | (52.30) | 48.12 | (385.62) | (115.31) | (25.33) |
Working Capital |
114.14 | 769.40 | (391.41) | (101.69) | 436.27 | — |
Capital Expenditures |
(735.75) | (95.19) | (16.99) | (590.81) | (58.57) | (1.57) |
Net Current Asset Value |
(2,414.85) | (1,515.03) | (1,212.08) | (1,131.93) | (341.09) | 0.00 |
EV/EBIT |
0.00 | 0.00 | 218.37 | 218.37 | 218.37 | 218.37 |
Capex to Sales |
2.31 | 0.19 | 0.03 | 0.92 | 0.11 | 0.03 |
Net Profit Margin |
(90.47%) | (281.57%) | (49.06%) | (335.20%) | 8.69% | (37.61%) |
Price to Operating Income |
0.00 | 0.00 | 145.82 | 145.82 | 145.82 | 145.82 |
| Other line items | ||||||
Depreciation/Fixed assets |
0.07 | 0.29 | 0.17 | 2.72 | 0.06 | 0.00 |
Cash ROIC |
(248.20%) | (40.35%) | (270.16%) | 136.08% | (29.90%) | 0.00% |
Accounts Receivable Turnover |
0.00 | 0.00 | 798.73 | 660.46 | 0.00 | 0.00 |
Accounts Payable Turnover |
3.87 | 4.48 | 3.64 | 19.37 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
163.73 | 18.05 | 149.06 | 30.98 | 13.87 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | 0.63 | 0.97 | — | — |
Average Payables |
72.69 | 87.01 | 104.20 | 32.63 | — | — |
Average Assets |
1,911.80 | 1,094.05 | 759.92 | 1,623.28 | 1,219.43 | — |
Average Common Equity |
(952.89) | (770.00) | (503.14) | 465.93 | — | — |
Columns are period end dates